America’s drug safety agency declined to review a next-gen flu vaccine that uses the same tech as the coronavirus shots ...

Moderna received a refusal-to-file letter from the FDA objecting to how it conducted a 40,000-person trial comparing its new ...

The company said the agency wouldn’t review its application on the grounds that the study testing the shot wasn’t sufficient.

By Rashika Singh Feb 11 (Reuters) - Shares of Moderna slumped nearly 9% in premarket trading on Wednesday after the U.S. Food ...

By Rashika Singh Feb 11 (Reuters) - Shares of Moderna fell 10.3% premarket on Wednesday after the U.S. Food and Drug ...

CNBC's Kelly Evans reports on the latest news.

The post Clinical Trials Show Moderna's New mRNA Flu Vaccine Is Safe and Effective. FDA Won't Even Consider It. appeared ...

A contingent of vaccine skeptics in the New Hampshire House of Representatives has again brought a slate of vaccine-related ...

Thursday to remove hepatitis B from the list of required vaccines in New Hampshire. Rep. Kelley Potenza, a Rochester ...

Moderna noted the FDA did not identify any specific safety concerns with the vaccine and that the rejection was inconsistent ...

An international research team has identified a novel HIV antibody that targets the virus at a particularly vulnerable site ...

Health Secretary Robert F. Kennedy Jr., who focused heavily on vaccine policy in 2025, will spend this year talking up ...